Non-structural protein 9 nsp9

UniProt ITasser SWISS Models alphafold D3Targets-2019-nCoV

May participate in viral replication by acting as a ssRNA-binding protein


Models/PDB

No model built for protein with good structural coverage represented in PDB

Models/PDB Model Chains_ID Selected Templates Model-Quality (MolProbity) PDB Coverage Model Coverage Sequence Length Oligomer States Oligomer Interfaces Model information
X-RAY_6W9Q A,B 6W9Q; Solved experimentally with good Coverage NA 100% 0.00% 113 Homo 2-mer

NA

NA


Binding Site Predictions

The fpocket calculation in this table only for structure present in the Model/PDB table above.

fpocket pocket score drug score hydrophobicity score polarity score
pocket0_nsp9 37.49 0.62 12.5 13
pocket1_nsp9 37.49 0.62 12.5 13
pocket2_nsp9 12.53 0.02 17.56 6
pocket3_nsp9 12.16 0.01 17.56 6
pocket4_nsp9 9.06 0.03 26.7 5
pocket5_nsp9 9.06 0.03 26.7 7
pocket6_nsp9 7.61 0.02 27.25 3
pocket7_nsp9 6.53 0.02 17.71 4

UniProt Viewer

Other PDB Hits

ID Method Resolution Å Chains Links
6wc1 X-RAY 2.4 A, B; PDBe
RCSB PDB
6w9q X-RAY 2.05 A PDBe
RCSB PDB
6wxd X-RAY 2 A,B PDBe
RCSB PDB
6w4b X-RAY 2.95 A,B PDBe
RCSB PDB
6wci X-RAY 2.4 A,B PDBe
RCSB PDB

Predictions of Mutations

pdb_id mutations deepddg maestro mCSM_ppi mCSM_Stability imutant provean
6w4b K82A -0.255 -0.18 -0.605 0.067 Decrease 0.895
6w4b K82C -0.462 -0.026 -0.019 -0.264 Increase 0.308
6w4b K82D -0.089 -0.381 -0.208 -0.112 Increase -0.044
6w4b K82E -0.4 -0.502 -0.239 -0.115 Increase 0.081
6w4b K82G -0.342 -0.269 -0.59 -0.097 Decrease 0.286
6w4b K82I -0.069 0.156 -0.635 0.415 Decrease 2.008
6w4b K82L -0.191 0.173 -0.635 0.415 Increase 1.234
6w4b K82M -0.25 0.118 0.462 0.027 Increase 1.084
6w4b K82N 0 -0.207 -0.73 0.167 Decrease 0.457
6w4b K82P -0.547 -0.236 -0.627 0.325 Increase -0.005
6w4b K82Q -0.165 -0.32 -0.549 0.018 Increase 0.158
6w4b K82R -0.265 -0.502 -0.602 -0.039 Decrease 0.028
6w4b K82S -0.095 -0.342 -0.605 -0.236 Increase 0.487
6w4b K82T -0.263 -0.218 -0.606 -0.108 Increase 1.131
6w4b K82V -0.376 -0.05 -0.627 0.325 Increase 2.249
6w4b K82Y -0.607 0.185 0.044 -0.02 Increase 0.56
6w4b T20D -0.642 -0.078 -0.218 -0.279 Decrease 0.901
6w4b T20E -0.727 0.199 -0.301 -0.33 Decrease -0.134
6w4b T20N -1.064 -0.02 -0.543 -0.436 Increase 0.242
6w4b T20P -1.755 0.142 -0.117 -0.451 Decrease 0.223
6w4b T20Q -1.9 0.116 -0.442 -0.717 Decrease -0.605
6w4b T20S -0.578 0.171 -0.423 -0.787 Decrease 0.037
6w4b T63D -0.256 -0.485 0.086 -0.002 Decrease -0.578
6w4b T63E -0.528 -0.681 0.067 -0.101 Decrease -0.613
6w4b T63G -0.761 0.041 -0.038 -0.303 Decrease -0.994
6w4b T63H -0.828 0.079 0.638 -0.498 Decrease -0.264
6w4b T63K -0.403 -0.24 0.275 -0.264 Decrease 0.022
6w4b T63M -0.281 -0.038 0.618 -0.171 Decrease -0.695
6w4b T63N -0.093 -0.211 -0.156 -0.056 Decrease 0.649
6w4b T63Q -0.37 -0.629 0.008 -0.285 Decrease -0.411
6w4b T63R -0.408 -0.445 0.282 -0.011 Decrease -0.708
6w4b T63S -0.45 -0.142 -0.139 -0.223 Decrease 0.434


Protein-Protein Interactions

We have mapped SARS CoV-2 human Protein-Protein Interactions from A SARS-CoV-2 protein interaction map reveals targets for drug repurposing human drug target interacted with SARS CoV-2 are highlighted in black arrow.






Responsive image